Tower Research Capital »

Pieris Pharmaceuticals shares owned by Tower Research Capital

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by Tower Research Capital from 13F filings

Historical chart of Tower Research Capital investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by Tower Research Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by Tower Research Capital

Quarter filed Position value Share count Share price at filing
2024-06-30 $3.3k 334 9.82

More positions owned by Tower Research Capital

Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Amazon (AMZN)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Broadcom (AVGO)
Tesla Motors (TSLA)
Advanced Micro Devices (AMD)
Costco Wholesale Corporation (COST)
Netflix (NFLX)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Adobe Systems Incorporated (ADBE)

View all positions for Tower Research Capital

Top funds holding Pieris Pharmaceuticals

BVF
BML Capital Management
Lynx1 Capital Management
Renaissance Technologies
CM Management
Frazier Life Sciences Management
BlackRock
BlackRock
Geode Capital Management
Citadel Advisors
Vanguard Group
Acadian Asset Management
Citigroup
Tower Research Capital
Group One Trading

View all funds holding Pieris Pharmaceuticals